Workup for Elevated Alkaline Phosphatase
The appropriate workup for elevated alkaline phosphatase (ALP) should begin with determining the source of elevation through isoenzyme testing, followed by targeted evaluation based on the likely origin (liver, bone, or intestinal). 1
Initial Assessment
Step 1: Determine the Source of Elevation
- Measure isoenzyme fractions of ALP to identify whether the elevation is from:
- Liver origin (hepatic ALP)
- Bone origin (bone ALP)
- Intestinal origin (intestinal ALP)
- Placental origin (in pregnant patients)
Step 2: Assess for Associated Laboratory Abnormalities
- Check other liver enzymes:
- Gamma-glutamyl transferase (GGT)
- Transaminases (AST, ALT)
- Bilirubin (total and direct)
- If GGT is elevated alongside ALP, this suggests hepatobiliary origin 1, 2
- If GGT is normal with elevated ALP, consider bone disease as the source 2
Workup Algorithm Based on Suspected Source
For Suspected Hepatobiliary Origin:
First-line imaging: Abdominal ultrasound to evaluate for:
- Biliary obstruction
- Liver parenchymal abnormalities
- Focal liver lesions 1
Second-line imaging if indicated:
- MRCP (magnetic resonance cholangiopancreatography) - gold standard for biliary tract evaluation with 86% sensitivity and 94% specificity 1
- CT scan or MRI for detailed liver assessment
Laboratory testing:
- Viral hepatitis panel
- Autoimmune markers (ANA, ASMA, AMA)
- Serum ceruloplasmin (to rule out Wilson's disease)
- IgG4 levels (if autoimmune cholangiopathy suspected) 1
For Suspected Bone Origin:
Laboratory testing:
- Calcium and phosphate levels
- Parathyroid hormone (PTH)
- Vitamin D levels
- Osteocalcin (correlates well with bone ALP, r = 0.78) 2
Imaging:
For Extremely High ALP Levels (>1000 U/L):
Pay special attention to:
- Malignancy (both hepatic infiltration and bone metastases)
- Sepsis (can have normal bilirubin)
- Biliary obstruction
- AIDS-related complications 3
Special Considerations
In Pregnant Women:
- Consider placental production as a cause of elevated ALP 1
In Children:
- Measure GGT alongside ALP, as ALP is naturally elevated due to bone growth 1
In Patients with Chronic Kidney Disease:
In Cancer Patients:
Common Pitfalls to Avoid
Failing to identify the source of ALP elevation
- Relying solely on GGT to differentiate liver from bone source can be misleading in up to 10% of cases 2
- Always consider measuring specific isoenzymes when the source is unclear
Missing malignancy
- Recent evidence shows that 57% of isolated ALP elevations of unclear etiology are due to underlying malignancy, with 47% of patients dying within an average of 58 months 4
Overlooking non-hepatic causes
- Normal liver enzymes and imaging don't rule out serious systemic conditions
- Consider sepsis, which can cause extremely high ALP with normal bilirubin 3
Inadequate follow-up
- The American Association for the Study of Liver Diseases recommends monitoring ALP levels at appropriate intervals:
- Mild elevations: repeat in 4-6 weeks
- Moderate elevations: repeat in 2-3 weeks
- Severe elevations: repeat in 1 week or sooner 1
- The American Association for the Study of Liver Diseases recommends monitoring ALP levels at appropriate intervals: